media, plasma, and serum.
Detects both natural and recombinant human VEGF.
Cat. No. QIA51 1 kit €664
Sample Type Average% Recovery Range
Cell Culture Media (n=5) 102 95-111%
Serum (n=5) 102 92
M NP_001155177.1,NP_001186.1 y n/d n/d
69 BID B4305 637 BID P NP_001187.1 y n/d n/d
76 BNIP3 B7931 664 BNIP3 M NP_004043.2 y n/d n/d
79 BTK, C-Terminal B0811 695 BTK P NP_000052.1 y n/d n/d
80 BTK, N-Terminal
M NP_001155177.1,NP_001186.1 y n/d n/d
69 BID B4305 637 BID P NP_001187.1 y n/d n/d
76 BNIP3 B7931 664 BNIP3 M NP_004043.2 y n/d n/d
79 BTK, C-Terminal B0811 695 BTK P NP_000052.1 y n/d n/d
80 BTK, N-Terminal
M NP_001155177.1,NP_001186.1 y n/d n/d
69 BID B4305 637 BID P NP_001187.1 y n/d n/d
76 BNIP3 B7931 664 BNIP3 M NP_004043.2 y n/d n/d
79 BTK, C-Terminal B0811 695 BTK P NP_000052.1 y n/d n/d
80 BTK, N-Terminal
Jones, W.K., et al. 2003. Cardiovasc. Toxicol. 3
229; Richmond, A. 2002. Nat. Rev. Immunol. 2, 664.
The IKK-NF-κB System: A Target for Inflammation and Cancer
NEW! Anti-NF-κB (p65), Human (Mouse
n/d y
662 Serine/Threonine Protein Phosphatase 2C α/β P8609 P y y n/d
663 AP2 gamma NA M y n/d n/d
664 SGK S5188 P y n/d n/d
665 SH-PTP2 (SHP-2) S3056 P y n/d n/d
666 Siah2 S7945 M y